Your browser doesn't support javascript.
loading
PR1-specific cytotoxic T lymphocytes are relatively frequent in umbilical cord blood and can be effectively expanded to target myeloid leukemia.
St John, Lisa S; Wan, Liping; He, Hong; Garber, Haven R; Clise-Dwyer, Karen; Alatrash, Gheath; Rezvani, Katayoun; Shpall, Elizabeth J; Bollard, Catherine M; Ma, Qing; Molldrem, Jeffrey J.
Afiliação
  • St John LS; Section of Transplantation Immunology, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Wan L; Department of Hematology, Shanghai Jiao Tong University Affiliated First People's Hospital, Shanghai, China.
  • He H; Section of Transplantation Immunology, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Garber HR; Section of Transplantation Immunology, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Clise-Dwyer K; Section of Transplantation Immunology, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Alatrash G; Section of Transplantation Immunology, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Rezvani K; Section of Transplantation Immunology, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Shpall EJ; Section of Transplantation Immunology, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Bollard CM; Center for Cancer and Immunology Research, Children's Research Institute, Washington, DC, USA.
  • Ma Q; Section of Transplantation Immunology, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Molldrem JJ; Section of Transplantation Immunology, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA. Electronic address: jmolldre@mdanderson.org.
Cytotherapy ; 18(8): 995-1001, 2016 08.
Article em En | MEDLINE | ID: mdl-27378343

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T Citotóxicos / Leucemia Mieloide / Antígeno HLA-A2 / Imunoterapia Adotiva / Mieloblastina / Sangue Fetal / Citotoxicidade Celular Dependente de Anticorpos Limite: Adult / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T Citotóxicos / Leucemia Mieloide / Antígeno HLA-A2 / Imunoterapia Adotiva / Mieloblastina / Sangue Fetal / Citotoxicidade Celular Dependente de Anticorpos Limite: Adult / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article